{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:40:22Z","timestamp":1793749222610,"version":"4.6.1"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-convulsive status epilepticus (NCSE) is a common definitive or exclusion diagnosis in patients with disorders of consciousness (DOC) on neurological or interdisciplinary intensive care units (ICU). Special expertise is required to ensure reliable diagnosis, targeted therapy management, and individual prognostication, particularly as NCSE is identified based solely on clinical and electroencephalographic findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>This narrative state-of-the-art review compiles and critically discusses the existing literature on various aspects of NCSE. We focus on the reliable initial diagnosis and further monitoring of NCSE using the Salzburg criteria and the 2HELP2B score, therapy options beyond current guideline recommendations, and prognosis assessment using established scores and metrics, such as STESS, SACE, EMSE, and END-IT. With compact tables and clear illustrations, comprehensive insights are presented in a concise structure to provide clear guidance for daily practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NCSE is a common and complex disease entity observed in the ICU that requires dedicated and specialised diagnostics, therapy, monitoring, and outcome assessment. Evidence-based recommendations are now available for each of these critical processes to guide caregivers and relatives. However, the availability of continuous (cEEG), quantitative (qEEG) electroencephalography in the ICU and expertise in its interpretation are limiting factors in many clinical settings. This problem is becoming increasingly pronounced due to the reduced or complete lack of reimbursement for c\/qEEG in the context of intensive care medicine in many countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-025-00435-7","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:32:51Z","timestamp":1761316371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Diagnosis, treatment, and outcome prediction of non-convulsive status epilepticus in unconscious patients in intensive care units"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-1674","authenticated-orcid":false,"given":"Laurent Maximilian","family":"Willems","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Beuchat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kellinghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"4","key":"435_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1212\/WNL.0b013e31829c5cfe","volume":"81","author":"NS Abend","year":"2013","unstructured":"Abend, N. S., Arndt, D. H., Carpenter, J. L., Chapman, K. E., Cornett, K. M., Gallentine, W. B., Giza, C. C., Goldstein, J. L., Hahn, C. D., Lerner, J. T., Loddenkemper, T., Matsumoto, J. H., McBain, K., Nash, K. B., Payne, E., Sanchez, S. M., Fernandez, I. S., Shults, J., Williams, K., \u2026 Dlugos, D. J. (2013). Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology, 81(4), 383\u2013391. https:\/\/doi.org\/10.1212\/WNL.0b013e31829c5cfe","journal-title":"Neurology"},{"issue":"8","key":"435_CR2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/epi.13056","volume":"56","author":"V Alvarez","year":"2015","unstructured":"Alvarez, V., Lee, J. W., Drislane, F. W., Westover, M. B., Novy, J., Dworetzky, B. A., & Rossetti, A. O. (2015). Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. Epilepsia, 56(8), 1275\u20131285. https:\/\/doi.org\/10.1111\/epi.13056","journal-title":"Epilepsia"},{"issue":"10","key":"435_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205789","volume":"13","author":"J An","year":"2018","unstructured":"An, J., Jonnalagadda, D., Moura, V. J., Purdon, P. L., Brown, E. N., & Westover, M. B. (2018). Variability in pharmacologically-induced coma for treatment of refractory status epilepticus. PLoS ONE, 13(10), Article e0205789. https:\/\/doi.org\/10.1371\/journal.pone.0205789","journal-title":"PLoS ONE"},{"issue":"5","key":"435_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamaneurol.2024.0108","volume":"81","author":"YK Au","year":"2024","unstructured":"Au, Y. K., Kananeh, M. F., Rahangdale, R., Moore, T. E., Panza, G. A., Gaspard, N., Hirsch, L. J., Fernandez, A., & Shah, S. O. (2024). Treatment of refractory status epilepticus with continuous intravenous anesthetic drugs: A systematic review. JAMA Neurology, 81(5), 534\u2013548. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0108","journal-title":"JAMA Neurology"},{"issue":"6","key":"435_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann, J. P., & Lowenstein, D. H. (2015). Status epilepticus in adults. The Lancet Neurology, 14(6), 615\u2013624. https:\/\/doi.org\/10.1016\/S1474-4422(15)00042-3","journal-title":"The Lancet Neurology"},{"issue":"1","key":"435_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18203","volume":"66","author":"I Beuchat","year":"2025","unstructured":"Beuchat, I., Novy, J., Alvarez, V., Rosenow, F., Kellinghaus, C., Ruegg, S., Tilz, C., Trinka, E., Unterberger, I., Uzelac, Z., Strzelczyk, A., & Rossetti, A. O. (2025). Association of early general anesthesia with outcome in adults with status epilepticus: A propensity-matched observational study. Epilepsia, 66(1), Article e7. https:\/\/doi.org\/10.1111\/epi.18203","journal-title":"Epilepsia"},{"issue":"2","key":"435_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/epi.17817","volume":"65","author":"I Beuchat","year":"2024","unstructured":"Beuchat, I., Novy, J., Rosenow, F., Kellinghaus, C., Ruegg, S., Tilz, C., Trinka, E., Unterberger, I., Uzelac, Z., Strzelczyk, A., & Rossetti, A. O. (2024). Staged treatment response in status epilepticus: Lessons from the SENSE registry. Epilepsia, 65(2), 338\u2013349. https:\/\/doi.org\/10.1111\/epi.17817","journal-title":"Epilepsia"},{"issue":"16","key":"435_CR8","doi-asserted-by":"publisher","first-page":"e1824","DOI":"10.1212\/WNL.0000000000201099","volume":"99","author":"I Beuchat","year":"2022","unstructured":"Beuchat, I., Rosenow, F., Kellinghaus, C., Trinka, E., Unterberger, I., Ruegg, S., Sutter, R., Tilz, C., Uzelac, Z., Rossetti, A. O., & Strzelczyk, A. (2022). Refractory status epilepticus: Risk factors and analysis of intubation in the Multicenter SENSE Registry. Neurology, 99(16), e1824\u2013e1834. https:\/\/doi.org\/10.1212\/WNL.0000000000201099","journal-title":"Neurology"},{"issue":"2","key":"435_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12028-022-01610-3","volume":"38","author":"F Brigo","year":"2023","unstructured":"Brigo, F., Turcato, G., Lattanzi, S., Orlandi, N., Turchi, G., Zaboli, A., Giovannini, G., & Meletti, S. (2023). Retrospective external validation of the Status Epilepticus Severity Score (STESS) to predict in-hospital mortality in adults with nonhypoxic status epilepticus: A machine learning analysis. Neurocritical Care, 38(2), 254\u2013262. https:\/\/doi.org\/10.1007\/s12028-022-01610-3","journal-title":"Neurocritical Care"},{"key":"435_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109388","volume":"147","author":"F Brigo","year":"2023","unstructured":"Brigo, F., Zaboli, A., Giovannini, G., Lattanzi, S., Orlandi, N., Turcato, G., & Meletti, S. (2023). Comparison of the status epilepticus severity score and the epidemiology-based mortality score in predicting 30-day mortality and status epilepticus cessation. Epilepsy & Behavior, 147, Article 109388. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109388","journal-title":"Epilepsy & Behavior"},{"issue":"1","key":"435_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., Laroche, S. M., Riviello, J. J., Jr., Shutter, L., Sperling, M. R., Treiman, D. M., Vespa, P. M., Neurocritical Care Society Status Epilepticus Guideline Writing, C. (2012). Guidelines for the evaluation and management of status epilepticus. Neurocritical Care, 17(1), 3\u201323. https:\/\/doi.org\/10.1007\/s12028-012-9695-z","journal-title":"Neurocritical Care"},{"issue":"7","key":"435_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41582-022-00664-3","volume":"18","author":"RJ Burman","year":"2022","unstructured":"Burman, R. J., Rosch, R. E., Wilmshurst, J. M., Sen, A., Ramantani, G., Akerman, C. J., & Raimondo, J. V. (2022). Why won\u2019t it stop? The dynamics of benzodiazepine resistance in status epilepticus. Nature Reviews Neurology, 18(7), 428\u2013441. https:\/\/doi.org\/10.1038\/s41582-022-00664-3","journal-title":"Nature Reviews Neurology"},{"key":"435_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.54029\/2024wpt","volume":"29","author":"B Chung","year":"2024","unstructured":"Chung, B., Lee, C., Kim, E., Kim, M., Kwon, O.-Y., Kim, D.-H., Yang, T.-W., Kang, J., Kim, Y.-S., & Park, H. (2024). The therapeutic effect of vagus nerve stimulation on super-refractory nonconvulsive status epilepticus. Neurology Asia, 29, 477\u2013481.","journal-title":"Neurology Asia"},{"issue":"8","key":"435_CR14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.clinph.2020.05.031","volume":"131","author":"FA Ciss\u00e9","year":"2020","unstructured":"Ciss\u00e9, F. A., Osman, G. M., Legros, B., Depondt, C., Hirsch, L. J., Struck, A. F., & Gaspard, N. (2020). Validation of an algorithm of time-dependent electro-clinical risk stratification for electrographic seizures (TERSE) in critically ill patients. Clinical Neurophysiology, 131(8), 1956\u20131961. https:\/\/doi.org\/10.1016\/j.clinph.2020.05.031","journal-title":"Clinical Neurophysiology"},{"issue":"10","key":"435_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/01.wnl.0000125184.88797.62","volume":"62","author":"J Claassen","year":"2004","unstructured":"Claassen, J., Mayer, S. A., Kowalski, R. G., Emerson, R. G., & Hirsch, L. J. (2004). Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology, 62(10), 1743\u20131748. https:\/\/doi.org\/10.1212\/01.wnl.0000125184.88797.62","journal-title":"Neurology"},{"issue":"6","key":"435_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/epi.17614","volume":"64","author":"P De Stefano","year":"2023","unstructured":"De Stefano, P., Baumann, S. M., Grzonka, P., Sarbu, O. E., De Marchis, G. M., Hunziker, S., Ruegg, S., Kleinschmidt, A., Quintard, H., Marsch, S., Seeck, M., & Sutter, R. (2023). Early timing of anesthesia in status epilepticus is associated with complete recovery: A 7-year retrospective two-center study. Epilepsia, 64(6), 1493\u20131506. https:\/\/doi.org\/10.1111\/epi.17614","journal-title":"Epilepsia"},{"issue":"6","key":"435_CR17","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1212\/WNL.0000000000012292","volume":"97","author":"P De Stefano","year":"2021","unstructured":"De Stefano, P., Baumann, S. M., Semmlack, S., Ruegg, S., Marsch, S., Seeck, M., & Sutter, R. (2021). Safety and Efficacy of Coma Induction Following First-Line Treatment in Status Epilepticus: A 2-Center Study. Neurology, 97(6), e564\u2013e576. https:\/\/doi.org\/10.1212\/WNL.0000000000012292","journal-title":"Neurology"},{"issue":"5","key":"435_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.neurol.2025.04.001","volume":"181","author":"E Dessevres","year":"2025","unstructured":"Dessevres, E., Valderrama, M., & Le Van Quyen, M. (2025). Artificial intelligence for the detection of interictal epileptiform discharges in EEG signals. Revue Neurologique, 181(5), 411\u2013419. https:\/\/doi.org\/10.1016\/j.neurol.2025.04.001","journal-title":"Revue Neurologique"},{"issue":"2","key":"435_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12028-024-01971-x","volume":"41","author":"TD Dittrich","year":"2024","unstructured":"Dittrich, T. D., Vock, D., Fisch, U., Hert, L., Baumann, S. M., Kliem, P. S. C., Ruegg, S., Marsch, S., De Marchis, G. M., & Sutter, R. (2024). Efficacy and tolerability of intranasal midazolam administration for antiseizure treatment in adults: A systematic review. Neurocritical Care, 41(2), 632\u2013650. https:\/\/doi.org\/10.1007\/s12028-024-01971-x","journal-title":"Neurocritical Care"},{"issue":"12","key":"435_CR20","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/epi.16382","volume":"60","author":"A Fechner","year":"2019","unstructured":"Fechner, A., Hubert, K., Jahnke, K., Knake, S., Konczalla, J., Menzler, K., Ronellenfitsch, M. W., Rosenow, F., & Strzelczyk, A. (2019). Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature. Epilepsia, 60(12), 2448\u20132458. https:\/\/doi.org\/10.1111\/epi.16382","journal-title":"Epilepsia"},{"issue":"1","key":"435_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000535085","volume":"87","author":"H Fenter","year":"2024","unstructured":"Fenter, H., Rossetti, A. O., & Beuchat, I. (2024). Continuous versus Routine Electroencephalography in the Intensive Care Unit: A Review of Current Evidence. European Neurology, 87(1), 17\u201325. https:\/\/doi.org\/10.1159\/000535085","journal-title":"European Neurology"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10309-022-00539-z","volume":"35","author":"U Fisch","year":"2022","unstructured":"Fisch, U., J\u00fcnger, A., Hert, L., R\u00fcegg, S., & Sutter, R. (2022). Therapeutically induced EEG burst-suppression pattern to treat refractory status epilepticus\u2014what is the evidence? Zeitschrift F\u00fcr Epileptologie, 35, 303\u2013309. https:\/\/doi.org\/10.1007\/s10309-022-00539-z","journal-title":"Zeitschrift F\u00fcr Epileptologie"},{"issue":"19","key":"435_CR23","doi-asserted-by":"publisher","first-page":"e1955","DOI":"10.1212\/WNL.0000000000207129","volume":"100","author":"U Fisch","year":"2023","unstructured":"Fisch, U., Junger, A. L., Baumann, S. M., Semmlack, S., De Marchis, G. M., Hunziker, S., Ruegg, S., Marsch, S., & Sutter, R. (2023). Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study. Neurology, 100(19), e1955\u2013e1966. https:\/\/doi.org\/10.1212\/WNL.0000000000207129","journal-title":"Neurology"},{"issue":"2","key":"435_CR24","doi-asserted-by":"publisher","first-page":"e207995","DOI":"10.1212\/WNL.0000000000207995","volume":"102","author":"U Fisch","year":"2024","unstructured":"Fisch, U., Junger, A. L., Baumann, S. M., Semmlack, S., De Marchis, G. M., Ruegg, S. J., Hunziker, S., Marsch, S., & Sutter, R. (2024). Association Between Dose Escalation of Anesthetics and Outcomes in Patients With Refractory Status Epilepticus. Neurology, 102(2), e207995. https:\/\/doi.org\/10.1212\/WNL.0000000000207995","journal-title":"Neurology"},{"key":"435_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.seizure.2017.03.018","volume":"48","author":"B Florea","year":"2017","unstructured":"Florea, B., Beniczky, S. A., Demeny, H., & Beniczky, S. (2017). May). Semiology of subtle motor phenomena in critically ill patients. Seizure, 48, 33\u201335. https:\/\/doi.org\/10.1016\/j.seizure.2017.03.018","journal-title":"Seizure"},{"issue":"4","key":"435_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17040048","volume":"17","author":"R Fratangelo","year":"2025","unstructured":"Fratangelo, R., Lolli, F., Scarpino, M., & Grippo, A. (2025). Point-of-care electroencephalography in acute neurological care: A narrative review. Neurology International, 17(4), Article 48. https:\/\/doi.org\/10.3390\/neurolint17040048","journal-title":"Neurology International"},{"key":"435_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13054-016-1221-9","volume":"20","author":"Q Gao","year":"2016","unstructured":"Gao, Q., Ou-Yang, T. P., Sun, X. L., Yang, F., Wu, C., Kang, T., Kang, X. G., & Jiang, W. (2016). Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Critical Care, 20, 46. https:\/\/doi.org\/10.1186\/s13054-016-1221-9","journal-title":"Critical Care"},{"issue":"1","key":"435_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1474-4422(24)00430-7","volume":"24","author":"JV Gettings","year":"2025","unstructured":"Gettings, J. V., Mohammad Alizadeh Chafjiri, F., Patel, A. A., Shorvon, S., Goodkin, H. P., & Loddenkemper, T. (2025). Diagnosis and management of status epilepticus: Improving the status quo. The Lancet Neurology, 24(1), 65\u201376. https:\/\/doi.org\/10.1016\/S1474-4422(24)00430-7","journal-title":"The Lancet Neurology"},{"issue":"15","key":"435_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34854","volume":"10","author":"P Girard","year":"2024","unstructured":"Girard, P., Bacq, A., Cloarec, P., Lesueur, C., Verleye, M., & Castagne, V. (2024). Stiripentol efficacy against status epilepticus and associated mortality in mice. Heliyon, 10(15), Article e34854. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34854","journal-title":"Heliyon"},{"issue":"1","key":"435_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser, T., Shinnar, S., Gloss, D., Alldredge, B., Arya, R., Bainbridge, J., Bare, M., Bleck, T., Dodson, W. E., Garrity, L., Jagoda, A., Lowenstein, D., Pellock, J., Riviello, J., Sloan, E., & Treiman, D. M. (2016). Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the guideline committee of the American Epilepsy Society. Epilepsy Currents, 16(1), 48\u201361. https:\/\/doi.org\/10.5698\/1535-7597-16.1.48","journal-title":"Epilepsy Currents"},{"issue":"3","key":"435_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/21646821.2025.2520094","volume":"65","author":"P Gomutbutra","year":"2025","unstructured":"Gomutbutra, P., Krongsut, S., & Lott, J. (2025). A systematic review and meta-analysis evaluating the clinical impact and accuracy of artificial intelligence in EEG for the early detection of nonconvulsive seizures. The Neurodiagnostic Journal, 65(3), 173\u2013196. https:\/\/doi.org\/10.1080\/21646821.2025.2520094","journal-title":"The Neurodiagnostic Journal"},{"issue":"8","key":"435_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16289","volume":"60","author":"RJM Goselink","year":"2019","unstructured":"Goselink, R. J. M., van Dillen, J. J., Aerts, M., Arends, J., van Asch, C., van der Linden, I., Pasman, J., Saris, C. G. J., Zwarts, M., & van Alfen, N. (2019). The difficulty of diagnosing NCSE in clinical practice; External validation of the Salzburg criteria. Epilepsia, 60(8), Article e88\u2013e92. https:\/\/doi.org\/10.1111\/epi.16289","journal-title":"Epilepsia"},{"issue":"1","key":"435_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13696998.2023.2288422","volume":"27","author":"A Green","year":"2024","unstructured":"Green, A., Wegman, M. E., & Ney, J. P. (2024). Economic review of point-of-care EEG. Journal of Medical Economics, 27(1), 51\u201361. https:\/\/doi.org\/10.1080\/13696998.2023.2288422","journal-title":"Journal of Medical Economics"},{"issue":"5","key":"435_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18380","volume":"66","author":"CD Hahn","year":"2025","unstructured":"Hahn, C. D., Novy, J., & Rossetti, A. O. (2025). Comparison of lacosamide, levetiracetam, and valproate as second-line therapy in adult status epilepticus: Analysis of a large cohort. Epilepsia, 66(5), Article e73. https:\/\/doi.org\/10.1111\/epi.18380","journal-title":"Epilepsia"},{"issue":"5","key":"435_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/clpt.2011.316","volume":"91","author":"M Hardmeier","year":"2012","unstructured":"Hardmeier, M., Zimmermann, R., Ruegg, S., Pfluger, M., Deuster, S., Suter, K., Donzelli, M., Drewe, J., Krahenbuhl, S., Fuhr, P., & Haschke, M. (2012). Intranasal midazolam: Pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clinical Pharmacology And Therapeutics, 91(5), 856\u2013862. https:\/\/doi.org\/10.1038\/clpt.2011.316","journal-title":"Clinical Pharmacology And Therapeutics"},{"issue":"3","key":"435_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s12028-023-01877-0","volume":"40","author":"MA Hawkes","year":"2024","unstructured":"Hawkes, M. A., Eliliwi, M., & Wijdicks, E. F. M. (2024). The origin of the burst-suppression paradigm in treatment of status epilepticus. Neurocritical Care, 40(3), 849\u2013854. https:\/\/doi.org\/10.1007\/s12028-023-01877-0","journal-title":"Neurocritical Care"},{"issue":"1","key":"435_CR37","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1212\/WNL.0000000000006689","volume":"92","author":"CE Hill","year":"2019","unstructured":"Hill, C. E., Blank, L. J., Thibault, D., Davis, K. A., Dahodwala, N., Litt, B., & Willis, A. W. (2019). Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients. Neurology, 92(1), e9\u2013e18. https:\/\/doi.org\/10.1212\/WNL.0000000000006689","journal-title":"Neurology"},{"issue":"1","key":"435_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch, L. J., Fong, M. W. K., Leitinger, M., LaRoche, S. M., Beniczky, S., Abend, N. S., Lee, J. W., Wusthoff, C. J., Hahn, C. D., Westover, M. B., Gerard, E. E., Herman, S. T., Haider, H. A., Osman, G., Rodriguez-Ruiz, A., Maciel, C. B., Gilmore, E. J., Fernandez, A., Rosenthal, E. S., \u2026 Gaspard, N. (2021). American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2021 version. Journal of Clinical Neurophysiology, 38(1), 1\u201329. https:\/\/doi.org\/10.1097\/WNP.0000000000000806","journal-title":"Journal of Clinical Neurophysiology"},{"issue":"1","key":"435_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12028-019-00704-9","volume":"31","author":"CJ Ho","year":"2019","unstructured":"Ho, C. J., Lin, C. H., Lu, Y. T., Shih, F. Y., Hsu, C. W., Tsai, W. C., & Tsai, M. H. (2019). Perampanel treatment for refractory status epilepticus in a neurological intensive care unit. Neurocritical Care, 31(1), 24\u201329. https:\/\/doi.org\/10.1007\/s12028-019-00704-9","journal-title":"Neurocritical Care"},{"issue":"9","key":"435_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/11633090-000000000-00000","volume":"26","author":"A Hottinger","year":"2012","unstructured":"Hottinger, A., Sutter, R., Marsch, S., & Ruegg, S. (2012). Topiramate as an adjunctive treatment in patients with refractory status epilepticus: An observational cohort study. CNS Drugs, 26(9), 761\u2013772. https:\/\/doi.org\/10.2165\/11633090-000000000-00000","journal-title":"CNS Drugs"},{"key":"435_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107139","volume":"109","author":"K Hubert","year":"2020","unstructured":"Hubert, K., Knake, S., Bauer, S., Voss, M., Rosenow, F., & Strzelczyk, A. (2020). Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature. Epilepsy & Behavior, 109, Article 107139. https:\/\/doi.org\/10.1016\/j.yebeh.2020.107139","journal-title":"Epilepsy & Behavior"},{"issue":"6","key":"435_CR42","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ana.25249","volume":"83","author":"AM Husain","year":"2018","unstructured":"Husain, A. M., Lee, J. W., Kolls, B. J., Hirsch, L. J., Halford, J. J., Gupta, P. K., Minazad, Y., Jones, J. M., LaRoche, S. M., Herman, S. T., Swisher, C. B., Sinha, S. R., Palade, A., Dombrowski, K. E., Gallentine, W. B., Hahn, C. D., Gerard, E. E., Bhapkar, M., Lokhnygina, Y., & Westover, M. B. (2018). Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures. Annals of Neurology, 83(6), 1174\u20131185. https:\/\/doi.org\/10.1002\/ana.25249","journal-title":"Annals of Neurology"},{"issue":"Suppl 8","key":"435_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1528-1167.2007.01345.x","volume":"48","author":"PW Kaplan","year":"2007","unstructured":"Kaplan, P. W. (2007). EEG criteria for nonconvulsive status epilepticus. Epilepsia, 48(Suppl 8), 39\u201341.","journal-title":"Epilepsia"},{"issue":"6","key":"435_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.410380609","volume":"38","author":"J Kapur","year":"1995","unstructured":"Kapur, J., & Coulter, D. A. (1995). Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons. Annals of Neurology, 38(6), 893\u2013900. https:\/\/doi.org\/10.1002\/ana.410380609","journal-title":"Annals of Neurology"},{"issue":"22","key":"435_CR45","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., Shinnar, S., Conwit, R., Meinzer, C., Cock, H., Fountain, N., Connor, J. T., & Silbergleit, R. (2019). Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. New England Journal of Medicine, 381(22), 2103\u20132113. https:\/\/doi.org\/10.1056\/NEJMoa1905795","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"435_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.seizure.2013.11.002","volume":"23","author":"C Kellinghaus","year":"2014","unstructured":"Kellinghaus, C., Berning, S., & Stogbauer, F. (2014). Use of oxcarbazepine for treatment of refractory status epilepticus. Seizure, 23(2), 151\u2013154. https:\/\/doi.org\/10.1016\/j.seizure.2013.11.002","journal-title":"Seizure"},{"issue":"3","key":"435_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ana.25416","volume":"85","author":"C Kellinghaus","year":"2019","unstructured":"Kellinghaus, C., Rossetti, A. O., Trinka, E., Lang, N., May, T. W., Unterberger, I., Ruegg, S., Sutter, R., Strzelczyk, A., Tilz, C., Uzelac, Z., & Rosenow, F. (2019). Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE). Annals Of Neurology, 85(3), 421\u2013432. https:\/\/doi.org\/10.1002\/ana.25416","journal-title":"Annals Of Neurology"},{"issue":"9","key":"435_CR48","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","volume":"36","author":"R Kienitz","year":"2022","unstructured":"Kienitz, R., Kay, L., Beuchat, I., Gelhard, S., von Brauchitsch, S., Mann, C., Lucaciu, A., Schafer, J. H., Siebenbrodt, K., Zollner, J. P., Schubert-Bast, S., Rosenow, F., Strzelczyk, A., & Willems, L. M. (2022). Benzodiazepines in the management of seizures and status epilepticus: A review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs, 36(9), 951\u2013975. https:\/\/doi.org\/10.1007\/s40263-022-00940-2","journal-title":"CNS Drugs"},{"key":"435_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020435","author":"PSC Kliem","year":"2022","unstructured":"Kliem, P. S. C., Tisljar, K., Baumann, S. M., Grzonka, P., De Marchis, G. M., Bassetti, S., Bingisser, R., Hunziker, S., Marsch, S., & Sutter, R. (2022). First-response ABCDE management of status epilepticus: A prospective high-fidelity simulation study. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm11020435","journal-title":"Journal of Clinical Medicine"},{"issue":"2","key":"435_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/WNP.0000000000000556","volume":"36","author":"MH Krogstad","year":"2019","unstructured":"Krogstad, M. H., Hogenhaven, H., Beier, C. P., & Kroigard, T. (2019). Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner. Journal of Clinical Neurophysiology, 36(2), 141\u2013145. https:\/\/doi.org\/10.1097\/WNP.0000000000000556","journal-title":"Journal of Clinical Neurophysiology"},{"issue":"2","key":"435_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12028-014-0070-0","volume":"22","author":"I Laccheo","year":"2015","unstructured":"Laccheo, I., Sonmezturk, H., Bhatt, A. B., Tomycz, L., Shi, Y., Ringel, M., DiCarlo, G., Harris, D., Barwise, J., Abou-Khalil, B., & Haas, K. F. (2015). Non-convulsive status epilepticus and non-convulsive seizures in neurological ICU patients. Neurocritical Care, 22(2), 202\u2013211. https:\/\/doi.org\/10.1007\/s12028-014-0070-0","journal-title":"Neurocritical Care"},{"key":"435_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.seizure.2016.01.008","volume":"39","author":"N Lang","year":"2016","unstructured":"Lang, N., Lange, M., Schmitt, F. C., Bos, M., Weber, Y., Evers, S., Burghaus, L., Kellinghaus, C., Schubert-Bast, S., Bosel, J., Lammers, T., Sabolek, M., van Baalen, A., Dziewas, R., Kraft, A., Ruf, S., & Stephani, U. (2016). Jul). Intravenous lacosamide in clinical practice-results from an independent registry. Seizure, 39, 5\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2016.01.008","journal-title":"Seizure"},{"key":"435_CR53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4097\/kjae.2007.53.3.387","volume":"53","author":"C Lee","year":"2007","unstructured":"Lee, C., & Son, Y. (2007). Isoflurane anesthesia therapy for nonconvulsive status epilepticus continuing after the control of convulsive status epilepticus: A case report. Korean Journal of Anesthesiology, 53, 387\u2013390. https:\/\/doi.org\/10.4097\/kjae.2007.53.3.387","journal-title":"Korean Journal of Anesthesiology"},{"key":"435_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","volume":"49","author":"M Leitinger","year":"2015","unstructured":"Leitinger, M., Beniczky, S., Rohracher, A., Gardella, E., Kalss, G., Qerama, E., Hofler, J., Hess Lindberg-Larsen, A., Kuchukhidze, G., Dobesberger, J., Langthaler, P. B., & Trinka, E. (2015). Salzburg consensus criteria for non-convulsive status epilepticus\u2013approach to clinical application. Epilepsy & Behavior, 49, 158\u2013163. https:\/\/doi.org\/10.1016\/j.yebeh.2015.05.007","journal-title":"Epilepsy & Behavior"},{"issue":"9","key":"435_CR55","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/epi.17694","volume":"64","author":"M Leitinger","year":"2023","unstructured":"Leitinger, M., Gaspard, N., Hirsch, L. J., Beniczky, S., Kaplan, P. W., Husari, K., & Trinka, E. (2023). Diagnosing nonconvulsive status epilepticus: Defining electroencephalographic and clinical response to diagnostic intravenous antiseizure medication trials. Epilepsia, 64(9), 2351\u20132360. https:\/\/doi.org\/10.1111\/epi.17694","journal-title":"Epilepsia"},{"issue":"2","key":"435_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12028-014-0080-y","volume":"22","author":"M Leitinger","year":"2015","unstructured":"Leitinger, M., Holler, Y., Kalss, G., Rohracher, A., Novak, H. F., Hofler, J., Dobesberger, J., Kuchukhidze, G., & Trinka, E. (2015). Epidemiology-based mortality score in status epilepticus (EMSE). Neurocritical Care, 22(2), 273\u2013282. https:\/\/doi.org\/10.1007\/s12028-014-0080-y","journal-title":"Neurocritical Care"},{"issue":"10","key":"435_CR57","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S1474-4422(16)30137-5","volume":"15","author":"M Leitinger","year":"2016","unstructured":"Leitinger, M., Trinka, E., Gardella, E., Rohracher, A., Kalss, G., Qerama, E., Hofler, J., Hess, A., Zimmermann, G., Kuchukhidze, G., Dobesberger, J., Langthaler, P. B., & Beniczky, S. (2016). Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: A retrospective study. The Lancet Neurology, 15(10), 1054\u20131062. https:\/\/doi.org\/10.1016\/S1474-4422(16)30137-5","journal-title":"The Lancet Neurology"},{"issue":"1","key":"435_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/epi.14607","volume":"60","author":"M Leitinger","year":"2019","unstructured":"Leitinger, M., Trinka, E., Giovannini, G., Zimmermann, G., Florea, C., Rohracher, A., Kalss, G., Neuray, C., Kreidenhuber, R., Hofler, J., Kuchukhidze, G., Granbichler, C., Dobesberger, J., Novak, H. F., Pilz, G., Meletti, S., & Siebert, U. (2019). Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. Epilepsia, 60(1), 53\u201362. https:\/\/doi.org\/10.1111\/epi.14607","journal-title":"Epilepsia"},{"issue":"4","key":"435_CR59","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.jemermed.2023.05.012","volume":"65","author":"B Long","year":"2023","unstructured":"Long, B., & Koyfman, A. (2023). Nonconvulsive status epilepticus: A review for emergency clinicians. The Journal of Emergency Medicine, 65(4), e259\u2013e271. https:\/\/doi.org\/10.1016\/j.jemermed.2023.05.012","journal-title":"The Journal of Emergency Medicine"},{"issue":"1","key":"435_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/epi4.12370","volume":"5","author":"SH Mahmoud","year":"2020","unstructured":"Mahmoud, S. H., Ho-Huang, E., & Buhler, J. (2020). Systematic review of ketogenic diet use in adult patients with status epilepticus. Epilepsia Open, 5(1), 10\u201321. https:\/\/doi.org\/10.1002\/epi4.12370","journal-title":"Epilepsia Open"},{"key":"435_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109464","volume":"148","author":"C Martellino","year":"2023","unstructured":"Martellino, C., Lagana, A., Atanasio, G., Lamanna, F., Attardo, S., Cascino, S., De Luca, M., Pardeo, O., Giacobbe, G., Tripepi, G., Roberti, R., Granata, F., Morace, C., Russo, E., & Labate, A. (2023). The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus. Epilepsy & Behavior, 148, Article 109464. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109464","journal-title":"Epilepsy & Behavior"},{"issue":"6","key":"435_CR62","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/MCO.0000000000000596","volume":"22","author":"TJW McDonald","year":"2019","unstructured":"McDonald, T. J. W., & Cervenka, M. C. (2019). Lessons learned from recent clinical trials of ketogenic diet therapies in adults. Current Opinion in Clinical Nutrition and Metabolic Care, 22(6), 418\u2013424. https:\/\/doi.org\/10.1097\/MCO.0000000000000596","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"3","key":"435_CR63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord, H., Boon, P., Engelsen, B., Gocke, K., Shorvon, S., Tinuper, P., & Holtkamp, M. (2010). EFNS guideline on the management of status epilepticus in adults. European Journal of Neurology, 17(3), 348\u2013355. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02917.x","journal-title":"European Journal of Neurology"},{"issue":"1","key":"435_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/epi.17830","volume":"65","author":"F Misirocchi","year":"2024","unstructured":"Misirocchi, F., Zilioli, A., Mannini, E., Lazzari, S., Mutti, C., Zinno, L., Parrino, L., De Stefano, P., & Florindo, I. (2024). Prognostic value of Salzburg nonconvulsive status epilepticus criteria: The SACE score. Epilepsia, 65(1), 138\u2013147. https:\/\/doi.org\/10.1111\/epi.17830","journal-title":"Epilepsia"},{"key":"435_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.541802","volume":"11","author":"B Miziak","year":"2020","unstructured":"Miziak, B., Chroscinska-Krawczyk, M., & Czuczwar, S. J. (2020). Neurosteroids and Seizure Activity. Front Endocrinol (Lausanne), 11, Article 541802. https:\/\/doi.org\/10.3389\/fendo.2020.541802","journal-title":"Neurosteroids and Seizure Activity. Front Endocrinol (Lausanne)"},{"issue":"1","key":"435_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s42466-024-00348-x","volume":"6","author":"L Moller","year":"2024","unstructured":"Moller, L., Simon, O. J., Junemann, C., Austermann-Menche, M., Bergmann, M. P., Habermehl, L., Menzler, K., Timmermann, L., Strzelczyk, A., & Knake, S. (2024). Stiripentol for the treatment of refractory status epilepticus. Neurol Res Pract, 6(1), 49. https:\/\/doi.org\/10.1186\/s42466-024-00348-x","journal-title":"Neurol Res Pract"},{"issue":"7","key":"435_CR67","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40261-015-0295-5","volume":"35","author":"EY Moreno Morales","year":"2015","unstructured":"Moreno Morales, E. Y., Fernandez Peleteiro, M., Bondy Pena, E. C., Dominguez Lorenzo, J. M., Pardellas Santiago, E., & Fernandez, A. (2015). Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus. Clinical Drug Investigation, 35(7), 463\u2013469. https:\/\/doi.org\/10.1007\/s40261-015-0295-5","journal-title":"Clinical Drug Investigation"},{"key":"435_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2023.100597","volume":"22","author":"K Nishiyama","year":"2023","unstructured":"Nishiyama, K., Kubota, Y., Ohbuchi, H., Yokosako, S., & Hagiwara, S. (2023). Nonconvulsive status epilepticus as sign of tumor recurrence. Epilepsy & Behavior Reports, 22, Article 100597. https:\/\/doi.org\/10.1016\/j.ebr.2023.100597","journal-title":"Epilepsy & Behavior Reports"},{"key":"435_CR69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.seizure.2021.01.014","volume":"86","author":"N Orlandi","year":"2021","unstructured":"Orlandi, N., Bartolini, E., Audenino, D., Coletti Moja, M., Urso, L., d\u2019Orsi, G., Pauletto, G., Nilo, A., Zinno, L., Cappellani, R., Zummo, L., Giordano, A., Dainese, F., Nazerian, P., Pescini, F., Beretta, S., Dono, F., Gaudio, L. D., Ferlisi, M., \u2026 Zanoni, T. (2021). Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy. Seizure, 86, 70\u201376. https:\/\/doi.org\/10.1016\/j.seizure.2021.01.014","journal-title":"Seizure"},{"key":"435_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2020.04.010","volume":"79","author":"AS Othman","year":"2020","unstructured":"Othman, A. S., Meletti, S., & Giovannini, G. (2020). The EEG diagnosis of NCSE: Concordance between clinical practice and Salzburg Criteria for NCSE. Seizure, 79, 1\u20137. https:\/\/doi.org\/10.1016\/j.seizure.2020.04.010","journal-title":"Seizure"},{"issue":"11","key":"435_CR71","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40263-023-01049-w","volume":"37","author":"L Purwien","year":"2023","unstructured":"Purwien, L., Schubert-Bast, S., Kieslich, M., Ronellenfitsch, M. W., Merker, M., Czabanka, M., Willems, L. M., Rosenow, F., & Strzelczyk, A. (2023). Trends and differences in status epilepticus treatment of children and adults over 10 years: A comparative study of medical records (2012\u20132021) from a University Hospital in Germany. CNS Drugs, 37(11), 993\u20131008. https:\/\/doi.org\/10.1007\/s40263-023-01049-w","journal-title":"CNS Drugs"},{"key":"435_CR72","doi-asserted-by":"publisher","DOI":"10.1177\/2324709619848816","volume":"7","author":"AB Ramos","year":"2019","unstructured":"Ramos, A. B., Cruz, R. A., Villemarette-Pittman, N. R., Olejniczak, P. W., & Mader, E. C., Jr. (2019). Dexamethasone as abortive treatment for refractory seizures or status epilepticus in the inpatient setting. Journal of Investigative Medicine High Impact Case Reports, 7, Article 2324709619848816. https:\/\/doi.org\/10.1177\/2324709619848816","journal-title":"Journal of Investigative Medicine High Impact Case Reports"},{"issue":"6","key":"435_CR73","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1001\/jamaneurol.2022.0609","volume":"79","author":"LE Roberg","year":"2022","unstructured":"Roberg, L. E., Monsson, O., Kristensen, S. B., Dahl, S. M., Ulvin, L. B., Heuser, K., Tauboll, E., Strzelczyk, A., Knake, S., Bechert, L., Rosenow, F., Beier, D., Beniczky, S., Kroigard, T., & Beier, C. P. (2022). Prediction of Long-term Survival After Status Epilepticus Using the ACD Score. JAMA Neurology, 79(6), 604\u2013613. https:\/\/doi.org\/10.1001\/jamaneurol.2022.0609","journal-title":"JAMA Neurology"},{"issue":"Suppl 6","key":"435_CR74","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/epi.12289","volume":"54","author":"MA Rogawski","year":"2013","unstructured":"Rogawski, M. A., Loya, C. M., Reddy, K., Zolkowska, D., & Lossin, C. (2013). Neuroactive steroids for the treatment of status epilepticus. Epilepsia, 54(Suppl 6), 93\u201398. https:\/\/doi.org\/10.1111\/epi.12289","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"435_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/epi.14494","volume":"59","author":"A Rohracher","year":"2018","unstructured":"Rohracher, A., Kalss, G., Neuray, C., Hofler, J., Dobesberger, J., Kuchukhidze, G., Kreidenhuber, R., Florea, C., Thomschewski, A., Novak, H. F., Pilz, G., Leitinger, M., & Trinka, E. (2018). Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients. Epilepsia, 59(Suppl 2), 234\u2013242. https:\/\/doi.org\/10.1111\/epi.14494","journal-title":"Epilepsia"},{"issue":"11","key":"435_CR76","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1111\/epi.16363","volume":"60","author":"A Rosati","year":"2019","unstructured":"Rosati, A., Boncristiano, A., Doccini, V., Pugi, A., Pisano, T., Lenge, M., De Masi, S., & Guerrini, R. (2019). Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study. Epilepsia, 60(11), 2255\u20132262. https:\/\/doi.org\/10.1111\/epi.16363","journal-title":"Epilepsia"},{"issue":"10","key":"435_CR77","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00115-020-01036-2","volume":"92","author":"F Rosenow","year":"2021","unstructured":"Rosenow, F., & Weber, J. (2021). S2k guidelines: status epilepticus in adulthood\u202f: Guidelines of the German Society for Neurology. Der Nervenarzt, 92(10), 1002\u20131030. https:\/\/doi.org\/10.1007\/s00115-020-01036-2","journal-title":"Der Nervenarzt"},{"issue":"19","key":"435_CR78","doi-asserted-by":"publisher","first-page":"e2372","DOI":"10.1212\/WNL.0000000000011879","volume":"96","author":"ES Rosenthal","year":"2021","unstructured":"Rosenthal, E. S., Elm, J. J., Ingles, J., Rogers, A. J., Terndrup, T. E., Holsti, M., Thomas, D. G., Babcock, L., Okada, P. J., Lipsky, R. H., Miller, J. B., Hickey, R. W., Barra, M. E., Bleck, T. P., Cloyd, J. C., Silbergleit, R., Lowenstein, D. H., Coles, L. D., Kapur, J., \u2026 Chamberlain, J. M. (2021). Early Neurologic Recovery, Practice Pattern Variation, and the Risk of Endotracheal Intubation Following Established Status Epilepticus. Neurology, 96(19), e2372\u2013e2386. https:\/\/doi.org\/10.1212\/WNL.0000000000011879","journal-title":"Neurology"},{"issue":"1","key":"435_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ncl.2024.07.002","volume":"43","author":"AO Rossetti","year":"2025","unstructured":"Rossetti, A. O. (2025). Refractory and Super-Refractory Status Epilepticus: Therapeutic Options and Prognosis. Neurologic Clinics, 43(1), 15\u201330. https:\/\/doi.org\/10.1016\/j.ncl.2024.07.002","journal-title":"Neurologic Clinics"},{"issue":"3","key":"435_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1212\/01.wnl.0000265819.36639.e0","volume":"69","author":"AO Rossetti","year":"2007","unstructured":"Rossetti, A. O., Logroscino, G., Liaudet, L., Ruffieux, C., Ribordy, V., Schaller, M. D., Despland, P. A., & Oddo, M. (2007). Status epilepticus: An independent outcome predictor after cerebral anoxia. Neurology, 69(3), 255\u2013260. https:\/\/doi.org\/10.1212\/01.wnl.0000265819.36639.e0","journal-title":"Neurology"},{"issue":"10","key":"435_CR81","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","volume":"255","author":"AO Rossetti","year":"2008","unstructured":"Rossetti, A. O., Logroscino, G., Milligan, T. A., Michaelides, C., Ruffieux, C., & Bromfield, E. B. (2008). Status epilepticus severity score (STESS): A tool to orient early treatment strategy. Journal Of Neurology, 255(10), 1561\u20131566. https:\/\/doi.org\/10.1007\/s00415-008-0989-1","journal-title":"Journal Of Neurology"},{"issue":"8","key":"435_CR82","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1212\/01.wnl.0000343006.60851.62","volume":"72","author":"AO Rossetti","year":"2009","unstructured":"Rossetti, A. O., Oddo, M., Liaudet, L., & Kaplan, P. W. (2009). Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology, 72(8), 744\u2013749. https:\/\/doi.org\/10.1212\/01.wnl.0000343006.60851.62","journal-title":"Neurology"},{"issue":"10","key":"435_CR83","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamaneurol.2020.2264","volume":"77","author":"AO Rossetti","year":"2020","unstructured":"Rossetti, A. O., Schindler, K., Sutter, R., R\u00fcegg, S., Zubler, F., Novy, J., Oddo, M., Warpelin-Decrausaz, L., & Alvarez, V. (2020). Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and no recent seizure. JAMA Neurology, 77(10), 1225. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2264","journal-title":"JAMA Neurology"},{"issue":"12","key":"435_CR84","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1001\/jama.2021.1727","volume":"325","author":"V Russotto","year":"2021","unstructured":"Russotto, V., Myatra, S. N., Laffey, J. G., Tassistro, E., Antolini, L., Bauer, P., Lascarrou, J. B., Szuldrzynski, K., Camporota, L., Pelosi, P., Sorbello, M., Higgs, A., Greif, R., Putensen, C., Agvald-Ohman, C., Chalkias, A., Bokums, K., Brewster, D., Rossi, E., \u2026 Investigators, I. S. (2021). Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA, 325(12), 1164\u20131172. https:\/\/doi.org\/10.1001\/jama.2021.1727","journal-title":"JAMA"},{"key":"435_CR85","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.yebeh.2011.08.028","volume":"22","author":"JC Sackellares","year":"2011","unstructured":"Sackellares, J. C., Shiau, D. S., Halford, J. J., LaRoche, S. M., & Kelly, K. M. (2011). Quantitative EEG analysis for automated detection of nonconvulsive seizures in intensive care units. Epilepsy & Behavior, 22, S69-73. https:\/\/doi.org\/10.1016\/j.yebeh.2011.08.028","journal-title":"Epilepsy & Behavior"},{"key":"435_CR86","unstructured":"SageTherapeutics. (2019). A study with SAGE-547 for super-refractory status epilepticus. Retrieved 06.06.2025 from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02477618"},{"issue":"11","key":"435_CR87","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1046\/j.1528-1157.2001.21301.x","volume":"42","author":"M Sahin","year":"2001","unstructured":"Sahin, M., Menache, C. C., Holmes, G. L., & Riviello, J. J. (2001). Outcome of severe refractory status epilepticus in children. Epilepsia, 42(11), 1461\u20131467. https:\/\/doi.org\/10.1046\/j.1528-1157.2001.21301.x","journal-title":"Epilepsia"},{"key":"435_CR88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2018.04.025","volume":"84","author":"E Santamarina","year":"2018","unstructured":"Santamarina, E., Gonzalez-Cuevas, M., Toledo, M., Jimenez, M., Becerra, J. L., Quilez, A., Suller, A., Mauri, J. A., Fernandez, A., Marinas, A., Quintana, M., & Puig, X. S. (2018). Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy. Epilepsy & Behavior, 84, 93\u201398. https:\/\/doi.org\/10.1016\/j.yebeh.2018.04.025","journal-title":"Epilepsy & Behavior"},{"issue":"8","key":"435_CR89","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/epi.16094","volume":"60","author":"E Santamarina","year":"2019","unstructured":"Santamarina, E., Parejo Carbonell, B., Sala, J., Gutierrez-Viedma, A., Miro, J., Asensio, M., Abraira, L., Falip, M., Ojeda, J., Lopez-Gonzalez, F. J., Rodriguez-Osorio, X., Mauri, J. A., Aiguabella, M., Garcia Morales, I., & Toledo, M. (2019). Use of intravenous brivaracetam in status epilepticus: A multicenter registry. Epilepsia, 60(8), 1593\u20131601. https:\/\/doi.org\/10.1111\/epi.16094","journal-title":"Epilepsia"},{"issue":"2","key":"435_CR90","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/epi.14623","volume":"60","author":"S Semmlack","year":"2019","unstructured":"Semmlack, S., Kaplan, P. W., Spiegel, R., De Marchis, G. M., Hunziker, S., Tisljar, K., Ruegg, S., Marsch, S., & Sutter, R. (2019). Illness severity scoring in status epilepticus-When STESS meets APACHE II, SAPS II, and SOFA. Epilepsia, 60(2), 189\u2013200. https:\/\/doi.org\/10.1111\/epi.14623","journal-title":"Epilepsia"},{"issue":"7","key":"435_CR91","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit, R., Durkalski, V., Lowenstein, D., Conwit, R., Pancioli, A., Palesch, Y., Barsan, W., Investigators, N. (2012). Intramuscular versus intravenous therapy for prehospital status epilepticus. New England Journal of Medicine, 366(7), 591\u2013600. https:\/\/doi.org\/10.1056\/NEJMoa1107494","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"435_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-015-0391-0","volume":"18","author":"A Sivaraju","year":"2016","unstructured":"Sivaraju, A., & Gilmore, E. J. (2016). Understanding and managing the ictal-interictal continuum in neurocritical care. Current Treatment Options In Neurology, 18(2), Article 8. https:\/\/doi.org\/10.1007\/s11940-015-0391-0. (2016, Feb).","journal-title":"Current Treatment Options In Neurology"},{"issue":"6","key":"435_CR93","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/epi4.13036","volume":"9","author":"N Specchio","year":"2024","unstructured":"Specchio, N., Auvin, S., Strzelczyk, A., Brigo, F., Villanueva, V., & Trinka, E. (2024). Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review. Epilepsia Open, 9(6), 2017\u20132036. https:\/\/doi.org\/10.1002\/epi4.13036","journal-title":"Epilepsia Open"},{"issue":"4","key":"435_CR94","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jamaneurol.2019.4656","volume":"77","author":"AF Struck","year":"2020","unstructured":"Struck, A. F., Tabaeizadeh, M., Schmitt, S. E., Ruiz, A. R., Swisher, C. B., Subramaniam, T., Hernandez, C., Kaleem, S., Haider, H. A., Cisse, A. F., Dhakar, M. B., Hirsch, L. J., Rosenthal, E. S., Zafar, S. F., Gaspard, N., & Westover, M. B. (2020). Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction. JAMA Neurology, 77(4), 500\u2013507. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4656","journal-title":"JAMA Neurology"},{"issue":"12","key":"435_CR95","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1001\/jamaneurol.2017.2459","volume":"74","author":"AF Struck","year":"2017","unstructured":"Struck, A. F., Ustun, B., Ruiz, A. R., Lee, J. W., LaRoche, S. M., Hirsch, L. J., Gilmore, E. J., Vlachy, J., Haider, H. A., Rudin, C., & Westover, M. B. (2017). Association of an electroencephalography-based risk score with seizure probability in hospitalized patients. JAMA Neurology, 74(12), 1419\u20131424. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2459","journal-title":"JAMA Neurology"},{"issue":"1","key":"435_CR96","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s42466-023-00306-z","volume":"6","author":"A Strzelczyk","year":"2024","unstructured":"Strzelczyk, A., Becker, H., Tako, L., Hock, S., Hattingen, E., Rosenow, F., & Mann, C. (2024). Fenfluramine for the treatment of status epilepticus: use in an adult with Lennox-Gastaut syndrome and literature review. Neurol Res Pract, 6(1), 10. https:\/\/doi.org\/10.1186\/s42466-023-00306-z","journal-title":"Neurol Res Pract"},{"key":"435_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/s10309-018-0211-0","author":"A Strzelczyk","year":"2018","unstructured":"Strzelczyk, A., Kellinghaus, C., & Trinka, E. (2018). Update on status epilepticus. Zeitschrift f\u00fcr Epileptologie. https:\/\/doi.org\/10.1007\/s10309-018-0211-0","journal-title":"Zeitschrift f\u00fcr Epileptologie"},{"issue":"4","key":"435_CR98","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/ane.13061","volume":"139","author":"A Strzelczyk","year":"2019","unstructured":"Strzelczyk, A., Knake, S., Kalviainen, R., Santamarina, E., Toledo, M., Willig, S., Rohracher, A., Trinka, E., & Rosenow, F. (2019). Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain. Acta Neurologica Scandinavica, 139(4), 369\u2013376. https:\/\/doi.org\/10.1111\/ane.13061","journal-title":"Acta Neurologica Scandinavica"},{"issue":"6","key":"435_CR99","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/ane.12403","volume":"132","author":"A Strzelczyk","year":"2015","unstructured":"Strzelczyk, A., Kortland, L. M., Knake, S., & Rosenow, F. (2015). Stiripentol for the treatment of super-refractory status epilepticus. Acta Neurologica Scandinavica, 132(6), 435\u2013439. https:\/\/doi.org\/10.1111\/ane.12403","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7","key":"435_CR100","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.seizure.2013.03.007","volume":"22","author":"A Strzelczyk","year":"2013","unstructured":"Strzelczyk, A., Reif, P. S., Bauer, S., Belke, M., Oertel, W. H., Knake, S., & Rosenow, F. (2013). Intravenous initiation and maintenance of ketogenic diet: Proof of concept in super-refractory status epilepticus. Seizure, 22(7), 581\u2013583. https:\/\/doi.org\/10.1016\/j.seizure.2013.03.007","journal-title":"Seizure"},{"key":"435_CR101","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yebeh.2017.03.028","volume":"70","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk, A., Steinig, I., Willems, L. M., Reif, P. S., Senft, C., Voss, M., Gaida, B., von Podewils, F., & Rosenow, F. (2017). May). Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals. Epilepsy & Behavior, 70, 177\u2013181. https:\/\/doi.org\/10.1016\/j.yebeh.2017.03.028","journal-title":"Epilepsy & Behavior"},{"issue":"6","key":"435_CR102","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/epi.13716","volume":"58","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk, A., Zollner, J. P., Willems, L. M., Jost, J., Paule, E., Schubert-Bast, S., Rosenow, F., & Bauer, S. (2017). Lacosamide in status epilepticus: Systematic review of current evidence. Epilepsia, 58(6), 933\u2013950. https:\/\/doi.org\/10.1111\/epi.13716","journal-title":"Epilepsia"},{"issue":"1","key":"435_CR103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40263-016-0389-5","volume":"31","author":"R Sutter","year":"2017","unstructured":"Sutter, R., De Marchis, G. M., Semmlack, S., Fuhr, P., Ruegg, S., Marsch, S., Ziai, W. C., & Kaplan, P. W. (2017). Anesthetics and outcome in status epilepticus: A matched two-center cohort study. CNS Drugs, 31(1), 65\u201374. https:\/\/doi.org\/10.1007\/s40263-016-0389-5","journal-title":"CNS Drugs"},{"issue":"Suppl 3","key":"435_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1528-1167.2012.03593.x","volume":"53","author":"R Sutter","year":"2012","unstructured":"Sutter, R., & Kaplan, P. W. (2012). Electroencephalographic criteria for nonconvulsive status epilepticus: Synopsis and comprehensive survey. Epilepsia, 53(Suppl 3), 1\u201351. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03593.x","journal-title":"Epilepsia"},{"issue":"9","key":"435_CR105","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrneurol.2013.154","volume":"9","author":"R Sutter","year":"2013","unstructured":"Sutter, R., Kaplan, P. W., & Ruegg, S. (2013). Outcome predictors for status epilepticus\u2013what really counts. Nature Reviews Neurology, 9(9), 525\u2013534. https:\/\/doi.org\/10.1038\/nrneurol.2013.154","journal-title":"Nature Reviews Neurology"},{"issue":"8","key":"435_CR106","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","volume":"82","author":"R Sutter","year":"2014","unstructured":"Sutter, R., Marsch, S., Fuhr, P., Kaplan, P. W., & Ruegg, S. (2014). Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study. Neurology, 82(8), 656\u2013664. https:\/\/doi.org\/10.1212\/WNL.0000000000000009","journal-title":"Neurology"},{"issue":"5","key":"435_CR107","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrneurol.2016.45","volume":"12","author":"R Sutter","year":"2016","unstructured":"Sutter, R., Semmlack, S., & Kaplan, P. W. (2016). Nonconvulsive status epilepticus in adults - Insights into the invisible. Nature Reviews Neurology, 12(5), 281\u2013293. https:\/\/doi.org\/10.1038\/nrneurol.2016.45","journal-title":"Nature Reviews Neurology"},{"issue":"17","key":"435_CR108","doi-asserted-by":"publisher","first-page":"e1948","DOI":"10.1212\/WNL.0000000000007365","volume":"92","author":"R Sutter","year":"2019","unstructured":"Sutter, R., Semmlack, S., Opic, P., Spiegel, R., De Marchis, G. M., Hunziker, S., Kaplan, P. W., Ruegg, S., & Marsch, S. (2019). Untangling operational failures of the Status Epilepticus Severity Score (STESS). Neurology, 92(17), e1948\u2013e1956. https:\/\/doi.org\/10.1212\/WNL.0000000000007365","journal-title":"Neurology"},{"issue":"19","key":"435_CR109","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1212\/WNL.0000000000008461","volume":"93","author":"R Sutter","year":"2019","unstructured":"Sutter, R., Tisljar, K., Opic, P., De Marchis, G. M., Bassetti, S., Bingisser, R., Hunziker, S., & Marsch, S. (2019). Emergency management of status epilepticus in a high-fidelity simulation: A prospective study. Neurology, 93(19), 838\u2013848. https:\/\/doi.org\/10.1212\/WNL.0000000000008461","journal-title":"Neurology"},{"issue":"2\u20133","key":"435_CR110","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.eplepsyres.2011.09.017","volume":"98","author":"AS Synowiec","year":"2012","unstructured":"Synowiec, A. S., Yandora, K. A., Yenugadhati, V., Valeriano, J. P., Schramke, C. J., & Kelly, K. M. (2012). The efficacy of topiramate in adult refractory status epilepticus: Experience of a tertiary care center. Epilepsy Research, 98(2\u20133), 232\u2013237. https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.09.017","journal-title":"Epilepsy Research"},{"issue":"10","key":"435_CR111","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka, E., Cock, H., Hesdorffer, D., Rossetti, A. O., Scheffer, I. E., Shinnar, S., Shorvon, S., & Lowenstein, D. H. (2015). A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 56(10), 1515\u20131523. https:\/\/doi.org\/10.1111\/epi.13121","journal-title":"Epilepsia"},{"key":"435_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13040936","author":"G Turcato","year":"2024","unstructured":"Turcato, G., Giovannini, G., Lattanzi, S., Orlandi, N., Turchi, G., Zaboli, A., Brigo, F., & Meletti, S. (2024). The role of early intubation in status epilepticus with out-of-hospital onset: A large prospective observational study. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm13040936","journal-title":"Journal of Clinical Medicine"},{"key":"435_CR113","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2016.12.020","volume":"373","author":"Y Uchida","year":"2017","unstructured":"Uchida, Y., Kato, D., Toyoda, T., Oomura, M., Ueki, Y., Ohkita, K., & Matsukawa, N. (2017). Combination of ketogenic diet and stiripentol for super-refractory status epilepticus: A case report. Journal of the Neurological Sciences, 373, 35\u201337. https:\/\/doi.org\/10.1016\/j.jns.2016.12.020","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"435_CR114","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/ane.12888","volume":"137","author":"Y Uchida","year":"2018","unstructured":"Uchida, Y., Terada, K., Madokoro, Y., Fujioka, T., Mizuno, M., Toyoda, T., Kato, D., & Matsukawa, N. (2018). Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity. Acta Neurologica Scandinavica, 137(4), 432\u2013437. https:\/\/doi.org\/10.1111\/ane.12888","journal-title":"Acta Neurologica Scandinavica"},{"issue":"10","key":"435_CR115","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1002\/acn3.52184","volume":"11","author":"LB Ulvin","year":"2024","unstructured":"Ulvin, L. B., Nilsen, K. B., Tauboll, E., Etholm, L., & Heuser, K. (2024). Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus. Annals of Clinical Translational Neurology, 11(10), 2685\u20132695. https:\/\/doi.org\/10.1002\/acn3.52184","journal-title":"Annals of Clinical Translational Neurology"},{"key":"435_CR116","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.seizure.2019.06.024","volume":"70","author":"LB Ulvin","year":"2019","unstructured":"Ulvin, L. B., Tauboll, E., Olsen, K. B., & Heuser, K. (2019). Aug). Predictive performances of STESS and EMSE in a Norwegian adult status epilepticus cohort. Seizure, 70, 6\u201311. https:\/\/doi.org\/10.1016\/j.seizure.2019.06.024","journal-title":"Seizure"},{"key":"435_CR117","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2021.20477","volume":"151","author":"V Urbano","year":"2021","unstructured":"Urbano, V., Novy, J., Schindler, K., Ruegg, S., Alvarez, V., Zubler, F., Oddo, M., Lee, J. W., & Rossetti, A. O. (2021). Continuous versus routine EEG in critically ill adults: Reimbursement analysis of a randomised trial. Swiss Medical Weekly, 151, Article w20477. https:\/\/doi.org\/10.4414\/smw.2021.20477","journal-title":"Swiss Medical Weekly"},{"issue":"6","key":"435_CR118","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/acn3.408","volume":"4","author":"H Vaitkevicius","year":"2017","unstructured":"Vaitkevicius, H., Husain, A. M., Rosenthal, E. S., Rosand, J., Bobb, W., Reddy, K., Rogawski, M. A., & Cole, A. J. (2017). First-in-man allopregnanolone use in super-refractory status epilepticus. Annals of Clinical and Translational Neurology, 4(6), 411\u2013414. https:\/\/doi.org\/10.1002\/acn3.408","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"9","key":"435_CR119","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1111\/epi.17343","volume":"63","author":"H Vaitkevicius","year":"2022","unstructured":"Vaitkevicius, H., Ramsay, R. E., Swisher, C. B., Husain, A. M., Aimetti, A., & Gasior, M. (2022). Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial. Epilepsia, 63(9), 2381\u20132391. https:\/\/doi.org\/10.1111\/epi.17343","journal-title":"Epilepsia"},{"issue":"6","key":"435_CR120","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/epi.17982","volume":"65","author":"L Vignatelli","year":"2024","unstructured":"Vignatelli, L., Tontini, V., Meletti, S., Camerlingo, M., Mazzoni, S., Giovannini, G., Pasini, E., Michelucci, R., Bisulli, F., Tinuper, P., & Di Vito, L. (2024). Clinical practice guidelines on the management of status epilepticus in adults: A systematic review. Epilepsia, 65(6), 1512\u20131530. https:\/\/doi.org\/10.1111\/epi.17982","journal-title":"Epilepsia"},{"issue":"8","key":"435_CR121","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s40263-020-00747-z","volume":"34","author":"LM Willems","year":"2020","unstructured":"Willems, L. M., Bauer, S., Jahnke, K., Voss, M., Rosenow, F., & Strzelczyk, A. (2020). Therapeutic options for patients with refractory status epilepticus in palliative settings or with a limitation of life-sustaining therapies: A systematic review. CNS Drugs, 34(8), 801\u2013826. https:\/\/doi.org\/10.1007\/s40263-020-00747-z","journal-title":"CNS Drugs"},{"key":"435_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216253","author":"LM Willems","year":"2022","unstructured":"Willems, L. M., Rosenow, F., Knake, S., Beuchat, I., Siebenbrodt, K., Struber, M., Schieffer, B., Karatolios, K., & Strzelczyk, A. (2022). Repetitive electroencephalography as biomarker for the prediction of survival in patients with post-hypoxic encephalopathy. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm11216253","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"435_CR123","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1016\/j.clinph.2021.07.026","volume":"132","author":"LM Willems","year":"2021","unstructured":"Willems, L. M., Trienekens, F., Knake, S., Beuchat, I., Rosenow, F., Schieffer, B., Karatolios, K., & Strzelczyk, A. (2021). EEG patterns and their correlations with short- and long-term mortality in patients with hypoxic encephalopathy. Clinical Neurophysiology, 132(11), 2851\u20132860. https:\/\/doi.org\/10.1016\/j.clinph.2021.07.026","journal-title":"Clinical Neurophysiology"},{"issue":"9","key":"435_CR124","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/jog.14031","volume":"45","author":"H Yoshida","year":"2019","unstructured":"Yoshida, H., Furugori, M., Kanatsuka, Y., Yamaguchi, S., & Shigeta, H. (2019). Case of anti-Hu antibody-mediated encephalopathy associated with ovarian cancer. Journal of Obstetrics and Gynaecology Research, 45(9), 1948\u20131951. https:\/\/doi.org\/10.1111\/jog.14031","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"1","key":"435_CR125","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1212\/wnl.47.1.83","volume":"47","author":"GB Young","year":"1996","unstructured":"Young, G. B., Jordan, K. G., & Doig, G. S. (1996). An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology, 47(1), 83\u201389. https:\/\/doi.org\/10.1212\/wnl.47.1.83","journal-title":"Neurology"},{"issue":"1","key":"435_CR126","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/epi.17442","volume":"64","author":"F Yuan","year":"2023","unstructured":"Yuan, F., Damien, C., & Gaspard, N. (2023). Prognostic scores in status epilepticus: A systematic review and meta-analysis. Epilepsia, 64(1), 17\u201328. https:\/\/doi.org\/10.1111\/epi.17442","journal-title":"Epilepsia"},{"key":"435_CR127","doi-asserted-by":"publisher","unstructured":"Laurent Maximilian, Willems Felix, Rosenow Adam, Strzelczyk (2023) (2023) Die Anwendung der Salzburg-Kriterien in der Diagnose des non-konvulsiven Status epilepticus Zusammenfassung Klinische Neurophysiologie 54(04):208\u2013213. https:\/\/doi.org\/10.1055\/a-2151-0390","DOI":"10.1055\/a-2151-0390"},{"key":"435_CR128","doi-asserted-by":"publisher","unstructured":"Laurent M., Willems Maja, Hochbaum Johann Philipp, Z\u00f6llner Juliane, Schulz Katja, Menzler Lisa, Langenbruch Stjepana, Kovac Susanne, Knake Felix, von Podewils Mario, Hamacher Hajo M., Hamer Jens\u2010Peter, Reese Katharina, Frey Felix, Rosenow Adam, Strzelczyk (2022) Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020 Abstract Epilepsia 63(6) 1591\u20131602. https:\/\/doi.org\/10.1111\/epi.v63.610.1111\/epi.17229","DOI":"10.1111\/epi.v63.610.1111\/epi.17229"},{"key":"435_CR129","doi-asserted-by":"publisher","unstructured":"Laurent M., Willems Maja, Hochbaum Katharina, Frey Juliane, Schulz Katja, Menzler Lisa, Langenbruch Stjepana, Kovac Ilka, Immisch Felix, von Podewils Mario, Hamacher Kai, Siebenbrodt Felix, Rosenow Jens\u2010Peter, Reese Adam, Strzelczyk (2022) Multicenter cross\u2010sectional study of the costs of illness and cost\u2010driving factors in adult patients with epilepsy Abstract Epilepsia 63(4) 904\u2013918. https:\/\/doi.org\/10.1111\/epi.v63.410.1111\/epi.17174","DOI":"10.1111\/epi.v63.410.1111\/epi.17174"},{"key":"435_CR130","doi-asserted-by":"publisher","unstructured":"Laurent M., Willems Felix, Rosenow Adam, Strzelczyk (2022) Therapeutische Optionen f\u00fcr Patienten mit Status epilepticus im h\u00f6heren Lebensalter Therapeutic options for patients with status epilepticus in old age Zusammenfassung Abstract Zeitschrift f\u00fcr Epileptologie 35(4) 345\u2013351. https:\/\/doi.org\/10.1007\/s10309-022-00525-5","DOI":"10.1007\/s10309-022-00525-5"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-025-00435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-025-00435-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-025-00435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:28:59Z","timestamp":1784035739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-025-00435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1186\/s42466-025-00435-7","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Laurent M. Willems received speaker\u2019s fees from StreamedUp GmbH outside the submitted work. Isabelle Beuchat reported no competing interests. Urs Fisch reported no competing interests. Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the ScientificSociety Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. Hereceived personal grants from UCB-pharma and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson. Christoph Kellinghaus has received speaker\u2019s honoraria from Angelini Pharma,Eisai, Jazz Pharmaceuticals, UCB, LivaNova. He has served on advisory boardsfor Angelini Pharma, Eisai and Marinus Pharma. Adam Strzelczyk reports personal fees and grants from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Jazz Pharmaceuticals, Longboard, Neuraxpharm, Stoke Therapeutics, Takeda, UCB, and UNEEG. Adam Strzelczyk reports that he is part of the editorial board of\n                      Neurological Research and Practice\n                      and editor-in-chief of\n                      Clinical Epileptology\n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}